InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Stueland Katherine, Chief Executive Officer. Insider active across 2 companies, notably GeneDx Holdings Corp.. Aggregated, 6 disclosures have been recorded. Total volume traded: €599k. The latest transaction was filed on 3 March 2026 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
047,684 shares0
Class A Common Stock
SEC:0001689575-26-000010·
047,684 shares0
Class A Common Stock
SEC:0001689575-26-000010:0·
€299,70011,506 shares@ €26.0472100.0% of flow
Common Stock
SEC:0000899243-21-024197·
€299,70011,506 shares@ €26.047250.0% of flow
Common Stock
SEC:0000899243-21-024197:0·
044,700 shares0
Common Stock
SEC:0000899243-21-018175:0·
044,700 shares0
Common Stock
SEC:0000899243-21-018175·
6 of 6 declarations
About Stueland Katherine
Katherine Stueland is the Chief Executive Officer at GeneDx Holdings Corp. and Invitae Corp. She leads business operations and is responsible for the company's growth strategy. With a strong background in the healthcare sector, Katherine Stueland is committed to innovation and improving the services offered by the companies. Her leadership is essential for achieving performance and development objectives.
